2 May 2023
LungLife AI, Inc.
(the “Company” or “LungLife”)
Confirmation of AGM
LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer, confirms that its Annual General Meeting ("AGM") will be held at 3:00 P.M. (BST) on Thursday 4 May 2023, at Investec Bank plc, 30 Gresham Street, London, EC2V 7QP.
For those shareholders who would like to dial into the meeting, please register by emailing LungLifeAI@walbrookpr.com or calling +44 (0)20 7933 8780 and the dial in link will be sent by email.
The Notice of AGM, Form of Direction and associated Form of Proxy are available on the Company’s website and have already been posted to those shareholders who have opted out of electronic communications. The resolutions to be proposed at the AGM are summarised in the Notice of AGM. All documents are available here: https://investors.lunglifeai.com/
The results of voting on the resolutions will be announced via a regulatory information service and posted on the Company’s website as soon as practicable after the AGM.
Click HERE for the full announcement.
"*" indicates required fields